Correlation Between Algernon Pharmaceuticals and Rasna Therapeutics

Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Rasna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Rasna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Algernon Pharmaceuticals and Rasna Therapeutics, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Rasna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Rasna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Rasna Therapeutics.

Diversification Opportunities for Algernon Pharmaceuticals and Rasna Therapeutics

0.0

Correlation Coefficient

Algernon Pharmaceuticals  Rasna Therapeutics

Pay attention - limited upside

The 3 months correlation between Algernon and Rasna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Rasna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rasna Therapeutics and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Rasna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rasna Therapeutics has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Rasna Therapeutics go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and Rasna Therapeutics

Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 33.11 times less return on investment than Rasna Therapeutics. But when comparing it to its historical volatility, Algernon Pharmaceuticals is 5.3 times less risky than Rasna Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Rasna Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1.01  in Rasna Therapeutics on October 12, 2024 and sell it today you would lose (0.61) from holding Rasna Therapeutics or give up 60.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Algernon Pharmaceuticals  vs.  Rasna Therapeutics

Algernon Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Algernon Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Algernon Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Rasna Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rasna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Rasna Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Algernon Pharmaceuticals and Rasna Therapeutics

The main advantage of trading using opposite Algernon Pharmaceuticals and Rasna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Rasna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rasna Therapeutics will offset losses from the drop in Rasna Therapeutics' long position.

The idea behind Algernon Pharmaceuticals and Rasna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.